KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Holders of 5% or more of KALV
Holders whose latest Schedule 13D or 13G filing reports 5% or more of KalVista Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 13G/A | 10.10%5.01M shares | – | Feb 3, 20251 filing | Feb 3, 2025 | SEC |
| Tang Capital Management LLC | 13G/A | 9.90%4.94M shares | – | May 15, 20251 filing | May 15, 2025 | SEC |
| Capital World Investors | 13G/A | 6.40%3.18M shares | – | May 13, 20251 filing | May 13, 2025 | SEC |
| Millennium Management LLC | 13G/A | 5.90%2.96M shares | – | Dec 30, 20251 filing | Dec 30, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on KalVista Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 30, 20254:28 PM ET | Millennium Management LLCand 3 others | 13G/A | 5.90%2.96M shares | – | Dec 23, 2025 | SEC |
| Aug 20, 20255:20 PM ET | Frazier Life Sciences Public Fund, L.P.and 16 others | 13D/A | 4.80%2.40M shares | –Below 5% | Aug 18, 2025 | SEC |
| May 15, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 9.90%4.94M shares | – | Mar 31, 2025 | SEC |
| May 13, 202511:44 AM ET | Capital World Investors | 13G/A | 6.40%3.18M shares | – | Mar 31, 2025 | SEC |
| Feb 3, 20257:43 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 10.10%5.01M shares | – | Jan 30, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell KalVista Pharmaceuticals, Inc. shares.
No Form 144 notices for KalVista Pharmaceuticals, Inc. are on file.